August 7, 2022

Tricia Oak

Business & Finance Excellency

Medolife Rx Announces Improvements to Administration and Improvements to AELIA’s Promoting Attempts

BURBANK, CA, Feb. 07, 2022 (World NEWSWIRE) — by means of NewMediaWire — Medolife Rx, Inc. (“Medolife”), a world-wide built-in biopharmaceutical enterprise with R&D, production, and client solution distribution, which is a vast majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), declared nowadays that the Company is in development of revamping their online advertising platform, commencing off with a adjust in the marketing and advertising and model growth for their AELIA manufacturer wellness products that utilize the company’s polarized components. Medolife thinks these variations will bring greater item awareness and enhanced online presence.

The Company’s manager of advertising and model enhancement, Maggie Dumais, has stepped down from their posture beneath mutual agreement with the Enterprise. In purchase to assist the Company’s eyesight of a new advertising and marketing strategy, Medolife is finalizing an agreement with a new director of marketing and model progress, whose title will be introduced at a later on date.

“We are excited with the new course that the Business is having with its AELIA merchandise and anticipate a favourable consequence,” says Medolife CEO Dr. Mikaelian. “The Company’s values, objectives and strategies will be presented in a way that reflects our mission to boost overall health and effectively-being with our expanding line of products.”

The Business also employed a new staff to oversee the overhaul of AELIA’s websites, product or service listings and social media existence. The Organization hopes that, with the support of these professional pros, their on the net platforms will see an maximize in sale conversions and client responses.

Medolife thanks its shareholders and purchasers for believing in them. The Business will have much more beneficial news coming out shortly.

About Medolife Rx

Medolife Rx, Inc. is a global biotechnology corporation with functions in medical research, manufacturing, and purchaser merchandise. Medolife Rx was made by means of the merger of Medolife, a private business established by Dr. Arthur Mikaelian, who pioneered the unlaying polarization technologies, and Quanta, Inc., a immediate-to-purchaser wellness merchandise portfolio firm. The Company’s lead medical progress plans include Escozine®, a proprietary formulation consisting of smaller molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company’s polarization technologies and is getting researched as a therapy of many indications, which include COVID-19 and most cancers. The Organization intends to go after item registration and drug approval in multiple nations around the world.

As a result of its subsidiary AELIA, Medolife manufactures and distributes consumer wellness merchandise in consumer places these as suffering relief, natural beauty, and basic wellness. AELIA products are designed employing Dr. Mikaelian’s polarization technologies, which applies developments in quantum biology to boost the potency of lively substances. Eventually, Quanta’s mission is to provide improved, much more efficient components to elevate merchandise efficacy, reduce waste, and aid more healthy, much more sustainable use.

Over and above its have medical and customer programs, the polarization technological know-how employed by Medolife and its subsidiaries has lots of opportunity purposes. From potentiating bio-substances, to producing far more-efficient carbon-trapping vegetation, to transformative anti-ageing alternatives, Medolife could have the prospect to upend how industrial and pharmaceutical products are designed and increase their rewards, though lowering their chemical concentration.

Ahead-On the lookout Statements

Harmless Harbor Assertion less than the U.S. Non-public Securities Litigation Reform Act of 1995: This release has statements that are forward-wanting in character which express the beliefs and expectations of management including statements about the Company’s expected benefits of functions or liquidity statements about projections, predictions, expectations, estimates or forecasts as to our small business, economic and operational outcomes and future economic functionality and statements of management’s aims and objectives and other related expressions concerning matters that are not historical information. In some cases, you can recognize ahead-looking statements by terminology this sort of as “foresee,” “estimate,” “plan,” “challenge,” “continuing,” “ongoing,” “assume,” “we imagine,” “we intend,” “may well,” “will,” “must,” “could,” and comparable expressions. This kind of statements are based on present-day designs, estimates and expectations and entail a number of recognised and unfamiliar pitfalls, uncertainties and other variables that could lead to the Company’s upcoming results, efficiency or achievements to vary appreciably from the outcomes, effectiveness or achievements expressed or implied by such forward-looking statements. These aspects and further details are talked about in the Firm’s filings with the Securities and Exchange Commission and statements in this release ought to be evaluated in gentle of these crucial aspects. Although we imagine that these statements are dependent upon affordable assumptions, we can not warranty foreseeable future success. Forward-seeking statements discuss only as of the day on which they are manufactured, and the Organization undertakes no obligation to update publicly or revise any forward-hunting assertion, irrespective of whether as a result of new details, long term developments or normally.

Contacts:

[email protected]

818-659-8052